1.Effect of inverted-Y urethral function-preserving holmium laser enucleation of the prostate on postoperative urinary incontinence.
Jin-Zhuo NING ; Jin-Runo WANG ; Fan CHENG ; Hao-Yong LI
National Journal of Andrology 2025;31(1):45-49
OBJECTIVE:
To investigate the effect of inverted-Y urethral function-preserving holmium laser enucleation of the prostate (HoLEP) on stress urinary incontinence after surgery in patients with BPH.
METHODS:
We retrospectively analyzed the clinical data on 109 cases of BPH treated in our hospital from June 2022 to May 2023 by traditional HoLEP with preservation of the apical prostatic urethral valve (group A, n = 52) or inverted-Y urethral function-preserving HoLEP (group B, n = 57). We recorded the intra- and post-operative parameters, evaluated the urinary incontinence status and post-void symptoms according to the International Continence Society standards, and analyzed the effect of inverted-Y versus traditional HoLEP in improving the postoperative urinary incontinence of the patients.
RESULTS:
The incidence rate of stress urinary incontinence after catheter removal was significantly lower in group B than in A (10.52% vs 26.92%, P = 0.027), and so was it at 2 weeks after surgery (1.75% vs 11.54%, P = 0.037), and at 1 month postoperatively (0% vs 7.69%, P = 0.033).
CONCLUSION
For the treatment of BPH, inverted-Y urethral function-preserving HoLEP is superior to traditional HoLEP with preservation of the apical prostatic urethral valve in improving stress urinary incontinence after surgery.
Humans
;
Male
;
Retrospective Studies
;
Lasers, Solid-State/therapeutic use*
;
Prostatic Hyperplasia/surgery*
;
Urethra/surgery*
;
Postoperative Complications/prevention & control*
;
Urinary Incontinence, Stress/etiology*
;
Prostatectomy/adverse effects*
;
Aged
;
Urinary Incontinence
;
Prostate/surgery*
2.Application of predictive nursing to the rehabilitation of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery.
Qian MENG ; Lei YU ; Xin WANG ; Meng-Ling WU ; Xiu-Qin YE
National Journal of Andrology 2025;31(9):823-826
OBJECTIVE:
To explore the efficacy of predictive nursing on the recovery of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery(ERAS).
METHODS
A total of 82 patients with benign prostatic hyperplasia who underwent surgery from February 2022 to February 2023 were divided into control group (n=41) with traditional care and the observation group (n=41) with predictive care based on the difference in nursing methods. And the clinical data of the two groups were compared. Results: The observation group showed lower incidence rates than the control group for all individual complications (urinary tract infection [2.44% vs 4.88%], hemorrhage [2.44% vs 7.32%], bladder spasm [0% vs 4.88%], and hypostatic pneumonia [0% vs 2.44%]), though none reached statistical significance (P>0.05). However, the total complication rate was significantly lower in the observation group (4.88% vs 19.51%, P < 0.05). Notably,the observation group demonstrated significantly lower IPSS scores (5.49±1.53 vs 10.35±1.77, P<0.05) and shorter hospital stays ([5.26±0.38] d vs [9.95±0.84] d, P<0.05). Additionally, nursing satisfaction was markedly higher in the observation group (92.68% vs 78.95%, P<0.05).Conclusion: The application of ERAS -guided anticipatory nursing in postoperative rehabilitation for patients with benign prostatic hyperplasia can significantly improve quality of life, reduce complication rates, shorten hospital stays, and enhance patient satisfaction.
Humans
;
Male
;
Prostatic Hyperplasia/nursing*
;
Endoscopy
;
Postoperative Complications/prevention & control*
;
Aged
;
Enhanced Recovery After Surgery
;
Middle Aged
;
Prostate/surgery*
3.Construction of risk prediction models of hypothermia after transurethral holmium laser enucleation of the prostate based on three machine learning algorithms.
Jun JIANG ; Shuo FENG ; Yingui SUN ; Yan AN
Journal of Southern Medical University 2025;45(9):2019-2025
OBJECTIVES:
To develop risk prediction models for postoperative hypothermia after transurethral holmium laser enucleation of the prostate (HoLEP) using machine learning algorithms.
METHODS:
We retrospectively analyzed the clinical data of 403 patients from our center (283 patients in the training set and 120in the internal validation set) and 120 patients from Weifang People's Hospital (as the external validation set). The risk prediction models were built using logistic regression, decision tree and support vector machine (SVM), and model performance was evaluated in terms of accuracy, recall, precision, F1 score and AUC.
RESULTS:
Operation duration, prostate weight, intraoperative irrigation volume, and being underweight were identified as the predictors of postoperative hypothermia following HoLEP. Among the 3 algorithms, SVM showed the best precision rate and accuracy in all the 3 data sets and the best area under the ROC (AUC) in the training set and validation set, followed by logistic regression, which had a similar AUC in the two data sets. SVM outperformed logistic regression and decision tree models in the validation set in precision, accuracy, recall, F1 score, and AUC, and performed well in the external validation set with better precision rate and accuracy than logistic regression and decision tree models but slightly lower recall rate, F1 index, and AUC value than the decision tree model. SVM outperformed logistic regression and decision tree models in precision, accuracy, F1 score, and AUC in the training set, but had slightly lower recall rate than the decision tree.
CONCLUSIONS
Among the 3 models, SVM has the best performance and generalizability for predicting post-HoLEP hypothermia risk to provide support for clinical decisions.
Humans
;
Male
;
Retrospective Studies
;
Machine Learning
;
Transurethral Resection of Prostate/adverse effects*
;
Hypothermia/etiology*
;
Prostatic Hyperplasia/surgery*
;
Algorithms
;
Lasers, Solid-State
;
Risk Assessment
;
Postoperative Complications
;
Decision Trees
;
Logistic Models
;
Aged
;
Middle Aged
;
Support Vector Machine
4.Risk factors for hypothermia after transurethral holmium laser enucleation of the prostate and development of a nomogram model.
Jun JIANG ; Shuo FENG ; Yingui SUN ; Yan AN
Journal of Central South University(Medical Sciences) 2024;49(11):1741-1750
OBJECTIVES:
Postoperative hypothermia is a common clinical complication with a high incidence rate, potentially adversely affecting postoperative recovery. Transurethral holmium laser enucleation of the prostate (HoLEP) is a minimally invasive procedure for benign prostatic hyperplasia (BPH). Offering advantages such as minimal bleeding, broad indications, and rapid postoperative recovery. However, research on risk factors for postoperative hypothermia following HoLEP remains limited, and predictive models for guiding clinical practice are lacking. This study aims to develop a predictive model for assessing the risk of postoperative hypothermia in HoLEP patients and to identify relevant risk factors.
METHODS:
Clinical data from patients who underwent HoLEP at affiliated Hospital of Shandong Second Medical University were retrospectively collected. Patients were categorized into a hypothermia group and a non-hypothermia group based on whether postoperative hypothermia occurred. Preoperative, intraoperative, and postoperative indicators were compared between the 2 groups. Least absolute shrinkage and selection operator (LASSO) regression combined with logistic regression analysis was used to analyze clinical data. A predictive model for assessing the risk of postoperative hypothermia after HoLEP was constructed and internally validated using bootstrap resampling.
RESULTS:
A total of 403 patients were included in the analysis, among whom 85 patients developed postoperative hypothermia, with an incidence rate of 21.1%. Logistic regression analysis identified operative duration (OR=1.009, 95% CI 1.003 to 1.015), underweight status (OR=9.881, 95% CI 4.038 to 24.910), and prostate weight (OR=1.021, 95% CI 1.012 to 1.030) as independent risk factors for postoperative hypothermia, and these variables were incorporated into the nomogram model. Internal validation showed strong discriminative ability of the nomogram, with an area under the receiver operating characteristic curve (AUC) of 0.755 (95% CI 0.686 to 0.820) and a C-index of 0.832 (95% CI 0.787 to 0.865). The calibration curve demonstrated good consistency between predicted and observed outcomes. Decision curve analysis showed that the nomogram provided greater clinical utility when the risk threshold for postoperative hypothermia was between 8% and 97%.
CONCLUSIONS
This study developed a nomogram model for predicting the risk of postoperative hypothermia in HoLEP patients, providing clinicians with a simple and effective predictive tool for individualized risk assessment and preoperative decision-making.
Humans
;
Male
;
Nomograms
;
Prostatic Hyperplasia/surgery*
;
Lasers, Solid-State/adverse effects*
;
Risk Factors
;
Retrospective Studies
;
Transurethral Resection of Prostate/methods*
;
Postoperative Complications/epidemiology*
;
Hypothermia/epidemiology*
;
Middle Aged
;
Aged
5.Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia.
Jing ZHOU ; Zhu-Feng PENG ; Pan SONG ; Lu-Chen YANG ; Zheng-Huan LIU ; Shuai-Ke SHI ; Lin-Chun WANG ; Jun-Hao CHEN ; Liang-Ren LIU ; Qiang DONG
Asian Journal of Andrology 2023;25(3):356-360
Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0-2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding (P = 0.79), urinary retention (P = 0.40), fever (P = 0.55), and readmission (P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program.
Male
;
Humans
;
Prostatic Hyperplasia/complications*
;
Quality of Life
;
Transurethral Resection of Prostate/adverse effects*
;
Treatment Outcome
;
Enhanced Recovery After Surgery
6.Six novel minimally invasive therapies for benign prostatic hyperplasia.
Journal of Zhejiang University. Medical sciences 2023;52(2):162-168
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.
Male
;
Humans
;
Prostatic Hyperplasia/complications*
;
Stents/adverse effects*
;
Embolization, Therapeutic/adverse effects*
;
Lower Urinary Tract Symptoms/surgery*
;
Treatment Outcome
;
Minimally Invasive Surgical Procedures
7.Application of ureteral access sheath in the operation of middle and lower ureteral calculi in patients with massive benign prostatic hyperplasia.
Jin Feng WANG ; Jian Hua GUO ; Hong Bin ZHU ; Zhong Sheng YE ; Wen Yun SHU ; Jian Hua WU ; Yi An ZHOU
Chinese Journal of Surgery 2022;60(2):164-168
Objective: To examine the effectiveness and safety of application of the ureteral access sheath in the treatment of middle or lower ureteral calculi in patients with large-volume benign prostatic hyperplasia above grade Ⅲ, which is expected to avoid the simultaneous or staged treatment of benign prostatic hyperplasia via eliminate the difficult angle and resistance of ureteroscopy caused by severe prostatic hyperplasia. Methods: From April 2018 to December 2020, the clinical data of 27 patients with massive benign prostatic hyperplasia above grade Ⅲ and middle and lower ureteral calculi treated with indwelling ureteral access sheath plus ureteroscopy holmium laser lithotripsy at Department of Urology, Zhejiang Quhua Hospital were retrospectively analyzed and followed up. All the patients were male, aged (69.7±12.8) years (range: 55 to 87 years). Prostate volume measured by transrectal ultrasound was (94.8±16.2) cm3 (range: 85 to 186 cm3). The ureteral access sheath was indwelled in advance, and then the semirigid ureteroscopy was introduced through the working channel of the sheath. Holmium laser lithotripsy was performed, and intraoperative and postoperative complications were recorded. Urinary abdominal plain X-ray or CT urography were performed at 1-and 2-month postopaerative to evaluate the residual stones and clinical efficacy. Results: The ureteral access sheath was placed and holmium laser lithotripsy under a semirigid ureteroscopy was performed successfully in all the 27 patients. In 2 patients, a second session of auxiliary procedure was required due to the large load of preoperative stones and residual stones after surgery, among whom 1 patient received extracorporeal shock wave lithotripsy and 1 patient underwent extracorporeal shock wave lithotripsy plus ureteroscopic lithotripsy. The stone free rate at 1-and 2-month postoperative were 92.6% (25/27) and 100% (27/27), respectively. There were no severe complications such as ureteral avulsion and perforation, perirenal hematoma, septic shock, severe hematuria, urinary retention, iatrogenic ureteral stricture occurred during and after the surgery. The ureteral calculus was wrapped by polyps heavily in 1 patient, he was diagnosed as ureteral stenosis 1 month postoperative, receiving laparoscopic resection of ureteral stricture plus anastomosis 3 months postoperative. Conclusions: In the operations of middle and lower ureteral calculi in patients with large-volume prostatic hyperplasia above grade Ⅲ, the ureteral access sheath can be placed first to effectively eliminate the difficult angle and resistance of ureteroscopy caused by severe prostatic hyperplasia, and then semirigid ureteroscopic lithotripsy can be safely performed. It could avoid the treatment of benign prostatic hyperplasia at the same time or by stages.
Aged
;
Aged, 80 and over
;
Humans
;
Lithotripsy
;
Lithotripsy, Laser
;
Male
;
Middle Aged
;
Prostatic Hyperplasia/complications*
;
Retrospective Studies
;
Treatment Outcome
;
Ureteral Calculi/surgery*
;
Ureteroscopy
8.Photoselective Vaporesection of the Prostate with an End-firing Lithium Triborate Crystal Laser.
Xin WANG ; Ming LIU ; Yao-Guang ZHANG ; Sheng-Cai ZHU ; Ben WAN ; Jian-Ye WANG
Chinese Medical Journal 2017;130(6):636-641
BACKGROUNDPhotoselective vaporization of the prostate is a technique that is widely used for the treatment of benign prostatic hyperplasia (BPH) and has pronounced advantages compared to the traditional transurethral resection of the prostate. Following the recent introduction of end-firing lithium triborate lasers, we have created a new technique called photoselective vaporesection of the prostate (PVRP). This study described our initial experience using the PVRP technique for the treatment of BPH.
METHODSThis prospective study included a total of 35 patients with BPH who underwent PVRP from August 2013 to July 2014. The chief clinical parameters were obtained and evaluated during the perioperative period and follow-up, including the International Prostate Symptom Score (IPSS), quality of life (QoL) score, maximum urinary flow rate, and prostate volume. All variables were evaluated for statistically significant differences compared to baseline values using the analysis of variance.
RESULTSThe mean subgroup IPSS and QoL scores significantly improved during follow-up; the respective decreases in IPSS storage score, IPSS voiding score, IPSS nocturia score, and QoL score were 75.3%, 83.6%, 51.4%, and 71.7%, respectively (all P < 0.001 compared with baseline). Three patients were diagnosed with prostate cancer based on postoperative pathological examinations. There were no serious perioperative complications.
CONCLUSIONThe PVRP technique demonstrates satisfactory short-term clinical outcomes and perioperative safety in the treatment of BPH.
Aged ; Aged, 80 and over ; Borates ; therapeutic use ; Humans ; Laser Therapy ; methods ; Lithium Compounds ; therapeutic use ; Male ; Middle Aged ; Perioperative Period ; Postoperative Complications ; Prospective Studies ; Prostate ; surgery ; Prostatic Hyperplasia ; surgery ; Treatment Outcome
9.Transurethral diode laser enucleation versus transurethral electrovaporization resection of the prostate for benign prostatic hyperplasia with different prostate volumes.
Duo LIU ; Li FAN ; Cheng LIU ; Xue-Jun LIU ; Dong-Sheng ZHU ; Jia-Gui MU ; Dong-Wei YAO ; Qun SONG
National Journal of Andrology 2017;23(3):217-222
Objective:
To compare the clinical effect of diode laser enucleation of the prostate (DIOD) with that of transurethral resection of the prostate (TURP) on benign prostate hyperplasia (BPH) with different prostate volumes.
METHODS:
This retrospective study included 256 BPH patients treated by DIOD (n = 141) or TURP (n = 115) from March 2012 to August 2015. According to the prostate volume, we divided the patients into three groups: <60 ml (42 for DIOD and 31 for TURP), 60-80 ml (51 for DIOD and 45 for TURP), and >80 ml (48 for DIOD and 39 for TURP). We obtained the relevant data from the patients before, during and at 6 months after surgery, and compared the two surgical strategies in operation time, perioperative levels of hemoglobin and sodium ion, post-operative urethral catheterization time and bladder irrigation time, pre- and post-operative serum PSA levels, International Prostate Symptoms Score (IPSS), post-void residual urine (PVR) volume and maximum urinary flow rate (Qmax), and incidence of post-operative complications among different groups.
RESULTS:
In the <60 ml group, there were no remarkable differences in the peri- and post-operative parameters between the two surgical strategies. In the 60-80 ml group, DIOD exhibited a significant superiority over TURP in the perioperative levels of hemoglobin ([3.25 ± 1.53] g/L vs [4.77 ± 1.67] g/L, P <0.05) and Na+ ([3.58 ± 1.27]mmol/L vs [9.67 ± 2.67] mmol/L, P <0.01), bladder irrigation time ([30.06 ± 6.22]h vs [58.32 ± 10.25] h, P <0.01), and urethral catheterization time ([47.61 ± 13.55] h vs [68.01 ± 9.69] h, P <0.01), but a more significant decline than the latter in the postoperative PSA level ([2.34 ± 1.29] ng/ml vs [1.09 ± 0.72] ng/ml, P <0.05), and similar decline was also seen in the >80 ml group ([3.35 ± 1.39] ng/ml vs [1.76 ± 0.91] ng/ml, P <0.05). No blood transfusion was necessitated and nor postoperative transurethral resection syndrome or urethral stricture observed in DIOD. However, the incidence rate of postoperative pseudo-urinary incontinence was significantly higher in the DIOD (22.7%, 32/141) than in the TURP group (7.83%, 9/115) (P <0.05).
CONCLUSIONS
DIOD, with its obvious advantages of less blood loss, higher safety, faster recovery, and more definite short-term effectiveness, is better than TURP in the treatment of BPH with medium or large prostate volume and similar to the latter with small prostate volume.
Humans
;
Lasers, Semiconductor
;
adverse effects
;
therapeutic use
;
Male
;
Operative Time
;
Organ Size
;
Postoperative Complications
;
etiology
;
Prostate
;
pathology
;
Prostatic Hyperplasia
;
pathology
;
surgery
;
Quality of Life
;
Retrospective Studies
;
Therapeutic Irrigation
;
Transurethral Resection of Prostate
;
adverse effects
;
methods
;
statistics & numerical data
;
Treatment Outcome
;
Urethral Stricture
;
etiology
;
Urinary Catheterization
;
Urinary Incontinence
;
etiology
10.Thulium laser vaporization versus transurethral resection of the prostate and risk factors for postoperative urethral stricture.
Wen SONG ; Tao WANG ; Qing LING ; Xia-Ming LIU ; Zhong CHEN ; Xiao-Dong SONG ; Xiao-Lin GUO ; Qian-Yuan ZHUANG ; Shao-Gang WANG ; Ji-Hong LIU
National Journal of Andrology 2017;23(12):1085-1088
Objective:
To compare thulium laser vaporization of the prostate (TLVP) and transurethral resection of the prostate (TURP) in the treatment of benign prostate hyperplasia (BPH) analyze the risk factors for postoperative urethral stricture.
METHODS:
From June 2015 to June 2016, 210 BPH patients in our hospital underwent TURP (n = 126) or TLVP (n = 84). We followed up the patients for 6 months, compared the effects of the two surgical strategies and analyzed the risk factors for postoperative urethral stricture by multivariate logistic regression analysis.
RESULTS:
Compared with TURP, TLVP achieved significantly shorter time of operation ([78.6 ± 27.5] vs [53.2 ± 21.6] min, P <0.01), postoperative bladder irrigation ([31.5 ± 2.9] vs [26.1 ± 3.7] h, P <0.01), urethral catheterization ([5.3 ± 1.7] vs [3.7 ± 1.5] d, P <0.01) and postoperative hospitalization ([7.9 ± 2.1] vs [5.5 ± 1.4] d, P <0.01) as well as lower urinary leukocyte count at 6 months after surgery ([32.1 ± 12.6] vs [24.9 ± 11.7] /μl, P <0.01) and incidence rate of postoperative complications (11.9% [15/126] vs 3.6% [3/84], P <0.05), particularly that of urethral stricture (7.9% [10/126] vs 1.2% [1/84], P <0.05). Logistic regression analysis showed that the preoperative urinary leukocyte count, postoperative urethral catheterization time, and surgical method were independent risk factors for postoperative urethral stricture.
CONCLUSIONS
TLVP, in comparison with TURP, has the advantages of definite effect, fast recovery, high safety and low incidence of postoperative urethral stricture. The main risk factors for postoperative urethral stricture include preoperative urinary tract infection, postoperative urethral catheterization time and surgical method.
Humans
;
Laser Therapy
;
adverse effects
;
methods
;
Male
;
Operative Time
;
Postoperative Complications
;
etiology
;
Prostatic Hyperplasia
;
surgery
;
Quality of Life
;
Regression Analysis
;
Risk Factors
;
Thulium
;
therapeutic use
;
Transurethral Resection of Prostate
;
adverse effects
;
Treatment Outcome
;
Urethral Stricture
;
etiology
;
Urinary Catheterization
;
Urinary Tract Infections
;
complications

Result Analysis
Print
Save
E-mail